When we first started The Next Platform a decade ago, there was not really much of a reason to cover the company’s datacenter ...

Citi lowered the firm’s price target on Nvidia (NVDA) to $163 from $175 and keeps a Buy rating on the shares ahead of the ...

Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including ...

Introducing new catalysts and positive earnings shifted Intel's return/risk curve signaling potential for a turnaround plan.

Shares of chipmaker Qualcomm fell about 5% in early trading on Thursday as a weak outlook for its patent licensing business ...